To see effect of some herbal drugs in the management of bronchial asthma (Tamaka Shwasa).

â??Comparative Study of Efficacy of â??Shunthyadi Churnaâ?? and â??Parnasapanchaka Kwathaâ?? in the Management of Tamaka Shwasa with special reference to Bronchial Asthmaâ??.

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/12/010845

Enrollment

Registered

2017-12-12

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Tamaka Shwasa (Bronchial asthma)

Interventions

Intervention1: Parnasapanchaka Kwatha: Parnasapanchaka Kwatha in dose of 40 ml with Prakshepa of Pippali Churna (2gm) before meals twice a day orally for 30 days. Control Intervention1: Shunthyadi Ch

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient willing to give informed consent to participate for 30 days. 2.Patients of either sex with age between 18 to 60 years. 3.Patient with stable Bronchial Asthma (Tamaka Shwasa) (as per WHO GINA Guideline) for at least 6 weeks prior to trial. 4.Patient presents with signs & symptoms of Tamaka Shwasa (Bronchial Asthma) as mentioned in Ayurvedic and modern texts. 5.Symptomatic patient with positive test of reversibility (If possible).

Exclusion criteria

Exclusion criteria: 1.Patients with severe Bronchial Asthma. 2.Patients present with co-morbid disorders. (D.M., T.B., R.A., Carcinoma etc.). 3.Patients suffering from pulmonary diseases other than bronchial asthma like COPD, Pleural effusion, Pneumonia. 4.Patients with poorly controlled Hypertension (i.e. Systolic > 160 mm of Hg and Diastolic > 100 mm of Hg) 5.Patients with concurrent serious Hepatic disorder or Renal Disorders, severe Pulmonary Dysfunction, or any other systemic/serious complications like Cerebrovascular / Cardiovascular disease that may jeopardize the study. 6.H/o hypersensitivity to the trial drug or any of its ingredients. 7.Patients who have completed participation in any other clinical trial during the past six months. 8.Pregnancy or lactating women. 9.Any other condition which the Investigator thinks may jeopardize the study.

Design outcomes

Primary

Measure	Time frame
Patients of either sex 18-60 yr old diagnosed with tamaka shwasa (Bronchial asthma) will be selected for relief in sign and symptomsTimepoint: 30 days	—

Secondary

Measure	Time frame
Assess comparative efficacy of shunthyadi churna and parnasapanchaka kwatha in tamaka shwasa (Bronchial asthma)Timepoint: 30 days	—

Countries

India

Contacts

Public ContactDr Shagufta Malhotra

National Institute of Ayurveda

joshirk1964@gmail.com9414322297

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026